Canaccord Genuity Reiterates a 'Buy' on Cepheid (CPHD); Lab Interviews Support GeneXpert Outlook
Tweet
Share
E-mailGet Alerts CPHD Hot Sheet
Price: $52.95 --0%
Rating Summary:
11 Buy, 14 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 18 | New: 20
Rating Summary:
11 Buy, 14 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 18 | New: 20
Join SI Premium – FREE
Canaccord Genuity reiterates a 'Buy' on Cepheid (NASDAQ: CPHD), PT increased from $36 to $40.
Canaccord analyst, Jeffrey Frelick, says, "We reiterate our rating on CPHD and increase our target to $40 following recent lab interviews of GeneXpert users that suggest upside to our prior consumable revenues estimate of $257M...Increasing 2012 estimates. Due to increases in utilization and our consumable estimates, we are raising our 2012E revenue and EPS to $327M and $0.40 from $310M and $0.35."
For more ratings news on Cepheid click here and for the rating history of Cepheid click here.
Shares of Cepheid closed at $32.37 yesterday.
Canaccord analyst, Jeffrey Frelick, says, "We reiterate our rating on CPHD and increase our target to $40 following recent lab interviews of GeneXpert users that suggest upside to our prior consumable revenues estimate of $257M...Increasing 2012 estimates. Due to increases in utilization and our consumable estimates, we are raising our 2012E revenue and EPS to $327M and $0.40 from $310M and $0.35."
For more ratings news on Cepheid click here and for the rating history of Cepheid click here.
Shares of Cepheid closed at $32.37 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- William Blair Downgrades Enovix Corporation (ENVX) to Market Perform
- Cullinan Oncology Inc. (CGEM) PT Raised to $27 at UBS
- Deutsche Bank Downgrades Workday (WDAY) to Hold
Create E-mail Alert Related Categories
Analyst CommentsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
